Title : Business Strategy for Pharmaceutical Company to Become the Market Leader in the Psychiatry Sector in Indonesia

Vol 5 No 12 (2022): Volume 05 Issue 12 December 2022

Article Date Published : 20 December 2022 | Page No.: 4686-4696 | Google Scholar | Crossref doi for this article

Abstract :

The prevalence of people with mental disorders in Indonesia continues to increase and its growth has been accelerated by the COVID-19 pandemic. The increase of the prevalence is also extrapolated to the market for psychiatric drugs in Indonesia which has grown by ten percent from 2018 to 2019 and 2019 to 2020. In the psychiatric market, 12 companies with the highest sales already account for 80% market share. Seeing the psychiatric drug market condition that continues to grow and its market share is still small, the low-market-share pharmaceutical companies must have a new business strategy to seize this opportunity and become one of the market leaders in the psychiatric drug market in Indonesia. This research was conducted to determine the main external and internal factors that affect psychiatric drug business and then provide alternative business strategies for pharmaceutical companies to become one of the market leaders in the psychiatric market. In this study, interviews were conducted with 18 experts in the pharmaceutical field. Data from interviews were analyzed using content analysis. Pharmaceutical market data from IQVIA was used in this study and analyzed using the growth-share matrix. The results of the content analysis show that the main external factors affecting the psychiatry business are categorized into legal, political, economic, market, technological and social aspects. Meanwhile, the key internal factors are categorized into brand, corporate culture, human assets and intellectual capital, organizational resources, originality, physical resources and relationships. Low-market-share companies in the growing market need to carry out an intensive strategy to increase its market share through product development, market penetration and market development.

Keywords :

Market Development, Market Penetration, Market Share, Product Development., Psychiatry Market, usiness Strategy

References :

  1. World Health Organization. (n.d). Mental Health. World Health Organization, Health Topics. Retrieved October 10, 2022, from https://www.who.int/health-topics/mental-health#tab=tab_1
  2. World Health Organization. (2022). Mental Disorders. World Health Organization, Newsroom. Retrieved October 10, 2022, from https://www.who.int/news-room/fact-sheets/detail/mental-disorders
  3. Ministry of Health of the Republic of Indonesia. (2019a). Riset Kesehatan Dasar 2018. Jakarta: Ministry of Health of the Republic of Indonesia.
  4. Ministry of Health of the Republic of Indonesia. (2019). Infodatin Situasi dan Pencegahan Bunuh Diri. Jakarta: Center of Data and Information, Ministry of Health of the Republic of Indonesia.
  5. Indonesian Psychiatric Association. (2022). Masalah Psikologis 2 Tahun Pandemi COVID-19 di Indonesia. Indonesian Psychiatric Association. Retrieved October 10, 2022, from http://pdskji.org/home
  6. (2022). Ethical N05 and N06 Sales Data, 2018–2021. IQVIA. Retrieved October 30, 2022, from https://hub.bi.iqvia.com/
  7. Schindler, P. S. (2019). Business research methods (13th ed.). New York: McGraw-Hill/Irwin.
  8. Marshall, B., Cardon, P., Poddar, A., & Fontenot, R. (2013). Does sample size matter in qualitative research?: A review of qualitative interviews in is research. Journal of Computer Information Systems, 54(1), 11–22. https://doi.org/10.1080/08874417.2013.11645667
  9. Erlingsson, C., & Brysiewicz, P. (2017). A hands-on guide to doing content analysis. African Journal of Emergency Medicine, 7(3), 93–99. https://doi.org/10.1016/j.afjem.2017.08.001
  10. Dian L. R., & Jenvitchuwong, S. (2021). Implementation of Halal Product Assurance in the pharmaceutical sector in Indonesia. Journal of Human Rights, Culture and Legal System, 1(3). doi:10.53955/jhcls.v1i3.19
  11. Limenta, M., & Lili, Y. I. (2022). Indonesia’s Local Content Requirements: Assessment with WTO Rules. Economic Research Institute for ASEAN and East Asia (ERIA), Working Papers DP-2021-47.
  12. Kondserovsky, S., Abecassis, M., & Galembert, M. (2022). Raw material shortage and its impact on the pharma industry. DLA Piper. Retrieved December 9, 2022, from https://lifesciences.dlapiper.com/post/102hpcs/raw-material-shortage-and-its-impact-on-the-pharma-industry
  13. Thompson, J. (2022). The Recession And Mental Health—And How Nonprofits Can Help. Forbes Nonprofit Council. Retrieved December 9, 2022, from https://www.forbes.com/sites/forbesnonprofitcouncil/2022/09/02/the-recession-and-mental-health-and-how-nonprofits-can-help/?sh=142541e62340
  14. Karim, F., Oyewande, A., Abdalla, L. F., Chaudhry Ehsanullah, R., & Khan, S. (2020). Social media use and its connection to Mental Health: A Systematic Review. Cureus. doi:10.7759/cureus.8627
  15. Latha, K., Meena, K. S., Pravitha, M. R., Dasgupta, M., & Chaturvedi, S. K. (2020). Effective use of social media platforms for promotion of Mental Health Awareness. Journal of Education and Health Promotion, 9(1), 124. https://doi.org/10.4103/jehp.jehp_90_20
  16. Hatami, H., Deravi, N., Danaei, B., Zangiabadian, M., Shahidi Bonjar, A. H., kheradmand, A., & Nasiri, M. J. (2022). Tele‐medicine and improvement of mental health problems in Covid‐19 pandemic: A systematic review. International Journal of Methods in Psychiatric Research, 31(3). https://doi.org/10.1002/mpr.1924
  17. Central Bureau of Statistics. (2022). Life Expectancy Rate (AHH) by Regency/City and Gender (Year), 2020-2021. Central Bureau of Statistics. Retrieved December 9, 2022, from https://www.bps.go.id/indicator/40/455/1/angka-harapan-hidup-ahh-menurut-kabupaten-kota-dan-jenis-kelamin.html
  18. Petrova, N. N., & Khvostikova, D. A. (2021). Prevalence, structure, and risk factors for mental disorders in older people. Advances in Gerontology, 11(4), 409–415. https://doi.org/10.1134/s2079057021040093
  19. Riedel, N. H., & Špacek, M. (2022). Innovation options and profitability of Pharmaceutical brand manufacturers. International Journal of Technology, 13(4), 890. https://doi.org/10.14716/ijtech.v13i4.5561
  20. Jekunen, A. (2014). Decision-making in product portfolios of Pharmaceutical Research and Development – managing streams of innovation in highly regulated markets. Drug Design, Development and Therapy, 2009. https://doi.org/10.2147/dddt.s68579
  21. Yu, Y., & Gupta, S. (2014). Pioneering advantage in generic drug competition. International Journal of Pharmaceutical and Healthcare Marketing, 8(2), 126–150. https://doi.org/10.1108/ijphm-11-2013-0063
  22. Anggriani, Y., Ramadaniati, H. U., Sarnianto, P., Pontoan, J., & Suryawati, S. (2020). The impact of pharmaceutical policies on medicine procurement pricing in Indonesia under the implementation of Indonesia’s Social Health Insurance System. Value in Health Regional Issues, 21, 1–8. https://doi.org/10.1016/j.vhri.2019.05.005
  23. Alateeq, D., Alsubaie, M. A., Alsafi, F. A., Alsulaiman, S. H., & Korayem, G. B. (2022). The use of dietary supplements for mental health among the Saudi population: A cross-sectional survey. Saudi Pharmaceutical Journal, 30(6), 742–749. https://doi.org/10.1016/j.jsps.2022.03.017
  24. Mohammadshahi, M., Haghighat, N., Shayanpour, S., Haghighizadeh, M. H., Rahmdel, S., & Rajaei, M. (2021). The effect of synbiotic and probiotic supplementation on mental health parameters in patients undergoing hemodialysis: A double-blind, randomized, placebo-controlled trial. Indian Journal of Nephrology, 31(2), 149. https://doi.org/10.4103/ijn.ijn_341_19
  25. United States Food and Drug Administration (US FDA). (2022). Novel Drug Approvals for 2022. US FDA. Retrieved December 9, 2022, from https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022
  26. Scher, J. U., & Schett, G. (2020). Key opinion leaders — a critical perspective. Nature Reviews Rheumatology, 17(2), 119–124. https://doi.org/10.1038/s41584-020-00539-1
  27. Mohammad Sadeghi, H., Adeli, I., Mousavi, T., Daniali, M., Nikfar, S., & Abdollahi, M. (2021). Drug repurposing for the management of depression: Where do we stand currently? Life, 11(8), 774. https://doi.org/10.3390/life11080774
  28. Schwartzberg, E., Barnett-Itzhaki, Z., Grotto, I., & Marom, E. (2017). Strategies for patient empowerment through the promotion of medicines in israel: Regulatory framework for the pharmaceutical industry. Israel Journal of Health Policy Research, 6(1). https://doi.org/10.1186/s13584-017-0175-y

Author's Affiliation

   Erwin .
School of Business and Management, Institut Teknologi Bandung, Jakarta, Indonesia

   Anh Dung Do
School of Business and Management, Institut Teknologi Bandung, Jakarta, Indonesia

Copyrights & License

Erwin ., Anh Dung Do, 2022

This work is licenced under a Creative Commons Attribution 4.0 International License.

Article Details

How to Cite :

Business Strategy for Pharmaceutical Company to Become the Market Leader in the Psychiatry Sector in Indonesia. Erwin, Anh Dung Do , 5(12), 4686-4696. Retrieved from https://ijcsrr.org/single-view/?id=8312&pid=8124

Most read articles by the same author(s)

Erwin ., Anh Dung Do,

View

218

Citation

Downloads

Article Details